‹ RXRX latest research

RXRX (Recursion Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed RXRX on 5 market nights between September 22, 2026 and October 5, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

5 calls 0 BUY · 5 HOLD · 0 SELL
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 5, 2026 HOLD $4.12 — / $3.48 -16.1% not yet
The stock is currently in a neutral technical state and facing fundamental headwinds, making it unsuitable for a buy recommendation.
October 2, 2026 HOLD $4.07 — / — +5.8% not yet
The stock is currently in a holding pattern, awaiting clearer directional signals or a more favorable risk-reward setup.
September 25, 2026 HOLD $3.89 — / — +10.2% not yet
The stock is currently in a neutral market regime and the technicals are mixed, making it unsuitable for a BUY at this time.
September 23, 2026 HOLD $4.05 — / — +11.6% not yet
The stock is currently in a holding pattern due to conflicting signals and risk factors.
September 22, 2026 HOLD $3.97 $5.22 / $3.70 -0.5% not yet
The post-earnings drift is still in play, but the stock is showing signs of stalling near resistance.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.